Dimensional Fund Advisors LP Avidity Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

$363 Billion
Q1 2024

A detailed history of Dimensional Fund Advisors LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,010,168 shares of RNA stock, worth $27.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,010,168

Previous 1,499,773 32.65%

Holding current value

$27.1 Million

Previous $13.6 Million 89.94%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.16 - $25.52 $4.48 Million - $12.5 Million	-489,605 Reduced 32.65%	1,010,168 $25.8 Million
Q4 2023 Feb 07, 2024	SELL	$4.87 - $9.37 $443,661 - $853,616	-91,101 Reduced 5.73%	1,499,773 $13.6 Million
Q3 2023 Nov 09, 2023	SELL	$6.3 - $11.35 $1.98 Million - $3.57 Million	-314,499 Reduced 16.51%	1,590,874 $10.1 Million
Q2 2023 Aug 09, 2023	BUY	$10.62 - $17.34 $6.76 Million - $11 Million	636,583 Added 50.17%	1,905,373 $21.1 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $5.32 Million - $8.89 Million	346,686 Added 37.6%	1,268,790 $19.5 Million

Q4 2022 Feb 09, 2023	BUY	$10.06 - $22.66 $2.64 Million - $5.94 Million	262,065 Added 39.7%	922,104 $20.5 Million
Q3 2022 Nov 10, 2022	BUY	$15.46 - $23.43 $2.32 Million - $3.51 Million	149,768 Added 29.35%	660,039 $10.8 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $1.54 Million - $2.82 Million	137,519 Added 36.89%	510,271 $7.41 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $2.46 Million - $4.12 Million	173,365 Added 86.95%	372,752 $6.88 Million
Q4 2021 Feb 09, 2022	BUY	$20.4 - $28.66 $2.29 Million - $3.21 Million	112,084 Added 128.39%	199,387 $4.74 Million
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $1.59 Million - $2.2 Million	87,303 New	87,303 $2.15 Million

Others Institutions Holding RNA

# of Institutions

164

Shares Held

71.6M

Call Options Held

182K

Put Options Held

55K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.4B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Avidity Biosciences, Inc. Transaction History